Home / Products / Peptides / Details
video
Bronchogen 20 Mg/vial – High-purity Peptide For Research Use – Chinese Supplier

Bronchogen 20 Mg/vial – High-purity Peptide For Research Use – Chinese Supplier

Bronchogen is a short-chain peptide (a tetrapeptide) composed of four amino acids with the sequence Ala-Glu-Asp-Leu (AEDL) and a molecular weight of approximately 446.45 Da. It belongs to a class of "peptide bioregulators" developed by the Russian scientist Professor V. Khavinson, with initial research focused on the repair and functional regulation of respiratory system tissues. Key preclinical evidence for the peptide comes from a study using a rat model of chronic obstructive pulmonary disease (COPD): following a 30-day course of Bronchogen administration, the characteristic markers of bronchial epithelial remodeling—such as goblet cell hyperplasia, squamous metaplasia, lymphocyte infiltration, and emphysema—were reversed. Furthermore, the population of ciliated cells was restored, levels of secretory IgA in bronchoalveolar lavage fluid increased, and neutrophilic inflammation was reduced.

Product Introduction

Application Scenarios
Based on existing research, the applications of Bronchogen focus on the structural and functional repair of the respiratory epithelium, primarily targeting:

Airway recovery following chronic irritant exposure: Such as interventions for bronchial epithelial remodeling after long-term exposure to factors like dust, cold air, or chlorine gas.

Reversal of airway remodeling in smokers or e-cigarette users: Observations in animal models-specifically the reversal of goblet cell hyperplasia and the restoration of ciliated cells-provide a mechanistic theoretical basis for this application.

Age-related decline in respiratory function: The general theoretical framework surrounding the Khavinson series of peptides posits that short peptides can reactivate gene expression programs silenced in aging cells through epigenetic regulation.

Cardiopulmonary support in bodybuilding: During periods of intense training, airway patency and respiratory muscle efficiency directly influence aerobic recovery. Some users employ it as an aid for cardiopulmonary conditioning; however, this usage lacks support from human clinical evidence and remains purely empirical.

 

 

 

Physical Mechanisms
The proposed mechanism of Bronchogen differs from that of conventional receptor agonists or hormonal peptides. According to the Khavinson school of thought, these ultra-short peptides can enter the cell nucleus and bind directly to the DNA double helix and core histones. By altering chromatin accessibility, they selectively upregulate or downregulate the transcriptional activity of specific genes. In experiments involving bronchial epithelial cell cultures, AEDL has been reported to upregulate key transcription factors involved in airway differentiation-such as NKX2-1, SCGB1A1, SCGB3A2, and FOXA1/2-thereby promoting the restoration of the epithelium to a normal, differentiated phenotype. In animal models, this transcriptional-level regulation manifests as the regression of goblet cell hyperplasia, the regeneration of ciliated cells, and the restoration of local immune barrier function (mediated by sIgA). The core characteristics of this mechanism dictate a slow onset of action coupled with long-lasting effects: while the plasma half-life is extremely short (ranging from tens of minutes to a few hours), the resulting changes in downstream gene expression can persist for weeks or even months after treatment ceases. Consequently, the primary mode of administration is a short-term, pulsed regimen (lasting 20–40 days) rather than continuous daily use.

 

 

 

Benefits in Bodybuilding
In the context of bodybuilding and strength training, the potential value of Bronchogen lies primarily in its indirect support for respiratory efficiency and cardiorespiratory recovery, rather than in any direct anabolic or fat-loss effects:

Maintenance of Airway Patency: High-intensity training-particularly during phases involving significant cardiovascular work or high-volume resistance training-can lead to hyperventilation and airway dryness, which may exacerbate stress-induced remodeling of the bronchial epithelium. Bronchogen is theorized to support the normalization of epithelial structure, thereby helping to maintain airway patency and effective clearance functions.

Assistance with Cardiorespiratory Recovery: Some users report that, following a 20–30 day cycle, they experience smoother deep breathing and reduced respiratory distress during rest periods between sets. It should be noted that these are anecdotal reports from users, not conclusions drawn from controlled clinical trials.

Timing in Relation to GH/Anabolic Cycles: Within the bodybuilding community, Bronchogen is typically utilized during "cruising" phases or periods of lower intensity, rather than being initiated concurrently with high-dose anabolic-androgenic steroids (AAS) or growth hormone (GH). The rationale is that the epigenetic effects of such peptide-based bioregulators require a relatively "clean" physiological environment to manifest effectively.

 

 

 

Dietary and Usage Precautions
As Bronchogen is not approved for human use, the following information is provided solely for scientific research and regulatory compliance purposes; it does not constitute medical or usage advice:
Intended exclusively for scientific research or raw material development; not for human injection, oral administration, or self-administration.
In powder form, it should generally be stored in a sealed container, protected from light, and kept at low temperatures. Once dissolved, repeated freeze-thaw cycles should be avoided.
If intended for animal research, all local ethical review requirements and regulations regarding the care and use of laboratory animals must be followed.
It should not be marketed or promoted for use in combination with human pharmaceuticals, hormones, or sports supplements.
For export, please ensure compliance with the destination country's regulations regarding HS codes, labeling, Certificates of Analysis (COA), Material Safety Data Sheets (MSDS), and declarations of intended use for scientific research.

 

 

 

Why Choose Us
For peptide products like Bronchogen-which lack a robust evidence base and carry significant quality risks-the choice of supplier determines whether you receive the "target tetrapeptide sequence" or a "mixture of unknown impurities." Here is why you should choose us:

Direct Manufacturer, Not a Reseller. We manage the entire production process-from peptide synthesis and purification to lyophilization and quality control-in-house. This eliminates the risks of batch contamination or improper storage conditions that can occur with intermediaries.

Professional Production Capabilities. We utilize Solid-Phase Peptide Synthesis (SPPS) combined with preparative HPLC purification. Each batch is accompanied by an HPLC purity profile and mass spectrometry (MS) data to verify the correct sequence and chemical purity. Given the discrepancies in existing literature regarding the Bronchogen sequence (citing either AEDL or ADEL), we rely on mass spectrometry data, ensuring full traceability for every batch.

Consistent Purity and Quality. We guarantee an HPLC purity of ≥98% with individual impurities ≤2%, maintaining strict control over batch-to-batch variability. For a short peptide consisting of only four amino acids, the primary challenge lies not in the sequence length, but in the removal of impurities and ensuring consistency across batches-a true reflection of a manufacturer's process control expertise.

Reliable Supply and After-Sales Support. We maintain regular stock and offer flexible packaging options (from milligram to gram scales) to meet the ongoing needs of scientific researchers. Every batch comes with a comprehensive test report, and we provide full traceability, as well as return or exchange options, should any quality issues arise. We explicitly state that our products are intended solely for scientific research purposes and are not for human use, clinical diagnosis, or therapeutic treatment. Adhering to this fundamental boundary is a reflection of our commitment to professional users.

 

 

 

FAQ:
Q: Where are your products manufactured?
A: Our products originate from Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 bottles/units.
Q: How soon will my order be shipped?
A: Orders for in-stock items are dispatched within 24 hours.
Q: What is the purity level of your products?
A: The standard purity is 99%.
Q: Which shipping carriers do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide a Certificate of Analysis (COA) and an HPLC (High-Performance Liquid Chromatography) report?
A: Yes, these can be provided; all products undergo professional testing prior to shipment.
Q: Do you offer OEM/private labeling services?
A: Yes, OEM/private labeling services are available, subject to meeting minimum order quantity requirements.
Q: How do you handle after-sales issues?
A: If a quality issue attributable to our production is identified after the customer receives the shipment, we offer free replacement or a refund. We operate with a pragmatic and responsible approach, addressing any concerns promptly and properly-we do not evade responsibility or shift blame, as we are fully committed to protecting our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.

Hot Tags: bronchogen 20 mg/vial – high-purity peptide for research use – chinese supplier, China bronchogen 20 mg/vial – high-purity peptide for research use – chinese supplier manufacturers, suppliers, factory

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag